144 related articles for article (PubMed ID: 31756289)
1. Increased diagnosis of autoimmune childhood-onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme-linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit.
Sugihara S; Yokota I; Mukai T; Mochizuki T; Nakayama M; Tachikawa E; Kawada Y; Minamitani K; Kikuchi N; Urakami T; Kawamura T; Kawasaki E; Kikuchi T; Amemiya S;
J Diabetes Investig; 2020 May; 11(3):594-602. PubMed ID: 31756289
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay.
Murata T; Tsuzaki K; Nirengi S; Watanabe T; Mizutani Y; Okada H; Tsukamoto M; Odori S; Nakagawachi R; Kawaguchi Y; Yoshioka F; Yamada K; Shimatsu A; Kotani K; Satoh-Asahara N; Sakane N
J Diabetes Investig; 2017 Jul; 8(4):475-479. PubMed ID: 27863109
[TBL] [Abstract][Full Text] [Related]
4. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
[TBL] [Abstract][Full Text] [Related]
6. Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice.
Oikawa Y; Kondo T; Shimada A; Seino Y; Kitaoka M
J Diabetes Investig; 2019 May; 10(3):685-689. PubMed ID: 30307126
[TBL] [Abstract][Full Text] [Related]
7. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus.
Dereke J; Nilsson C; Landin-Olsson M; Hillman M
Diabet Med; 2012 Dec; 29(12):e436-9. PubMed ID: 22924602
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus.
Sugihara S; Konda S; Wataki K; Kobayashi Y; Murata A; Miyamoto S; Kubo H; Yamaguchi A; Sasaki N; Niimi H
Acta Paediatr; 1996 May; 85(5):558-63. PubMed ID: 8827099
[TBL] [Abstract][Full Text] [Related]
10. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
11. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
[TBL] [Abstract][Full Text] [Related]
13. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
[TBL] [Abstract][Full Text] [Related]
14. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
[TBL] [Abstract][Full Text] [Related]
15. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.
Vianello M; Keir G; Giometto B; Betterle C; Tavolato B; Thompson EJ
Eur J Neurol; 2005 Apr; 12(4):294-9. PubMed ID: 15804247
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
19. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
